Rx · Prescription required

Tesamorelin

Egrifta®

FDA-approved to reduce excess abdominal fat in adults with HIV who have lipodystrophy.

Drug class: Growth hormone–releasing factor analog
How it is given: Once-daily injection
Prescription: Required
Dispensed by: DiRx Inc. · licensed pharmacy

FDA status: Brand-name versions (Egrifta®) are FDA-approved. If your doctor prescribes a compounded version, it is prepared by a licensed pharmacy for you and is not itself FDA-approved; your doctor and pharmacist explain which version you receive.

Locked

Pricing is shared after you speak with our team and a licensed doctor approves treatment. Clinics see pricing after account verification.

Talk to our team Call (954) 420-7747

Important safety information

Not for use during pregnancy. Can raise blood sugar. Common side effects include joint pain, injection-site reactions, swelling and muscle pain. Your doctor will check your health history first.

This is not the complete list of risks. Read the full prescribing information and talk to your doctor. Official label (DailyMed) ↗

How to get started

Message us on WhatsApp or call (954) 420-7747.
Talk with a licensed doctor, who reviews your health history and decides if this medicine is right for you.
If prescribed, our team shares pricing and a licensed pharmacy fills your order.

Watch & learn

Videos: how it works and how it is used

Independent videos from doctors, hospitals and health educators on YouTube. They are for general education; your doctor gives the instructions for your treatment.

Explainer